Search

everythinglearnresearchcommunity

for

Search:↓

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The supplement helps improve hair growth and reduce hair shedding.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The study found average numbers for different types of hair follicles in the scalp and observed differences between men and women, suggesting reasons for more common hair shedding in women.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

The supplement significantly improves hair density and appearance in people with hair loss.

Most adult women experiencing hair loss are aged 21-40, with the most common type being female pattern hair loss. Trichoscopy is a useful tool for diagnosing different types of hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Androgenetic alopecia is the most common cause of hair loss at Sohag University Hospital's hair clinic.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Patients with chronic kidney disease on hemodialysis often have skin problems.

The guide helps dermatologists diagnose and treat different types of hair loss.

Alopecia is a condition causing hair loss that can impact looks and mental health.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

The pull test and wash test are cheap, easy methods to diagnose hair loss.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.